4
Drug interactions and their potential toxic effects among patients in Gjilan region, Kosovo
Authors: Driton Shabani, Adnan Bozalia, Petrit Bara, Klejda Hudhra, Ledian Malaj, Besnik Jucja
Number of views: 296
In the public health and medical field, but more specifically in the clinical settings, particular attention should be made in order to avoid adverse drug interactions and their potential toxic effects. In any case, regardless of the efforts to avoid drug interactions and their resulting toxic effects, for individuals taking at least two medications (drugs), the risk of a drug interaction has been estimated at 15%. On the other hand, for individuals taking at least five medications the risk of adverse drug interactions increases up to 40%.
Finally, for individuals taking at least seven medications the risk amounts to a disturbing 80%. Hence, the risk of a toxic medication interaction is real considering that more than one half of non-institutionalized adults older than 65 years take five or more different medications, and 12% use ten or more medications.In the United States of America, among the hospitalized patients, adverse drug interactions are estimated to be as high as the fourth leading cause of death. Toxic drug interactions can occur when two or more medications compete in such a way that their pharmacologic interaction causes a detrimental physiologic response.Alternatively, toxic drug interaction can occur when a medication is prescribed in excessive amounts, or when one medication produces inconvenient consequences although it is prescribed according to established guidelines. It has been argued that this last effect is often the most difficult to predict because drug absorption and metabolism can vary with age, concomitant illness, gastric motility, pH of the gastrointestinal milieu, genetic variation, smoking, or some other obscure physiologic parameter. It has been demonstrated that the most dangerous drug combinations in the nursing home population involve warfarin interactions with non-steroidal anti-inflammatory drugs (NSAIDs), sulfonamides, macrolides, or quinolones; angiotensin-converting enzyme (ACE) inhibitor interactions with potassium supplements or spironolactone; digoxin interactions with amiodarone; and theophylline interactions with quinolones. However, the available information on drug interactions and their health effects is scarce for Kosovo including Gjilan region. In this framework, there is an obvious need to conduct population-based studies assessing the potential toxic effects of drug interactions in Kosovo, a post-war country in the Western Balkans.
Keywords: drug interactions, Gjilan region, Kosovo, toxic effects.